Policy Brief
Revisiting Interchangeability to Realize the Benefit of Biosimilars
Brian Canter, Trevan Locke, Mark McClellan
2021
Read MorePolicy Brief
Originator Biologics and Biosimilars: Payment Policy Solutions to Increase Price Competition While Maintaining Market Sustainability in Medicare Part B
Nitzan Arad, Derick Rapista, Marianne Hamilton Lopez, Mark McClellan
2021
Read MoreComment Letter
CMS Comment Letter on Proposed Coverage Pathway
Mark McClellan, Beena Bhuiyan Khan, Hannah Graunke, Marianne Hamilton Lopez
2021
Read MorePolicy Brief
Ensuring Sustainability and Reach of COVID Vaccine Distribution
John Bollinger, Katie Greene, Katie Huber, Mark McClellan, and the National Academy for State Health Policy.
2021
Read More